Company intelligence / Profile preview

EA Genomics

Morrisville, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

EA Genomics, a division of Q2 Solutions, provides comprehensive genomic services to support drug discovery, clinical trials, and companion diagnostic development. Originally founded as Expression Analysis, the company specializes in high-throughput sequencing, gene expression profiling, and advanced bioinformatics. They offer a wide range of platforms including Illumina, PacBio, and NanoString to deliver high-quality genomic data for pharmaceutical and biotechnology clients. Their services are integrated into global clinical trial workflows to facilitate precision medicine and biomarker identification.

Industry: Drug Discovery Services

Partnerships

IlluminaPacBioNanoString TechnologiesThermo Fisher Scientific

Beyond the preview

Go deeper on EA Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EA Genomics.

Explore the full profile